On ECHEMI
Home > Drugs > Myo-aminoglycan for injection

Myo-aminoglycan for injection

Function and Efficacy

Pharmacological action: Nucleotides and various amino acids (essential amino acids) are important substances involved in human life activities. They can improve blood circulation disorders, reduce vascular resistance, increase myocardial oxygen utilization, promote the activity of the hematopoietic system, increase the number of white blood cells, increase vascular elasticity, and prevent vascular sclerosis.

Ingredients

This product contains a variety of cardiovascular active substances, the main components of which include atrial peptides, calcitonin gene-related peptides and nucleotides (nucleosides) such as adenosine triphosphate (adenosine), in addition to more than 20 amino acids and their metabolic intermediates.

Name Description Content CAS NO. Manufacturer
atriopeptin IIIngredients

Improve blood circulation disorders, reduce vascular resistance, increase myocardial oxygen utilization, etc.

More
98084-69-6 0
Adenosine triphosphateIngredients

Improve blood circulation disorders, reduce vascular resistance, increase myocardial oxygen utilization, etc.

More
56-65-5 2
5-Methyl-2'-deoxycytidineIngredients

Participate in human life activities, improve blood circulation disorders, reduce vascular resistance, increase myocardial oxygen utilization, etc.

More
838-07-3 0
L-tert-LeucineIngredients

Essential amino acids participate in human life activities, improve blood circulation disorders, reduce vascular resistance, increase myocardial oxygen utilization, promote the enhancement of hematopoietic system activities, increase the number of white blood cells, and increase vascular elasticity and prevent vascular sclerosis.

More
20859-02-3 0

Appearance

This product is light yellow to dark yellow mass or amorphous solid.

Indication

It promotes the body's metabolism. It is used for muscle atrophy, neurogenic edema, paralysis caused by cerebrovascular accident, neurasthenia syndrome, etc. Ischemic heart and cerebrovascular disease, diabetes, microvascular disease. Congestive heart failure. Various types of hypertension and its complications. Hemiplegia caused by cerebrovascular accident, cerebral arteriosclerosis, muscle atrophy, neurasthenia syndrome. Prevent and treat angina pectoris, myocardial infarction, toxic and hemorrhagic shock

Usage and Dosage

Intramuscular injection: 1-2 times a day or as directed by a doctor; intravenous drip: 1-2 times a day, two weeks as a course of treatment

Adverse Reactions

Some patients experience chills, fever, dizziness, slightly elevated body temperature, and irritability. These symptoms may disappear after slowing down the drip rate or stopping the medication.

Precautions

It is contraindicated for those who are allergic to any ingredient in this product.

Special Population Medication

Precautions for children: Not yet clear. Precautions for pregnancy and lactation: There is still a lack of research data on the effectiveness and safety of this product for pregnant and lactating women. Precautions for the elderly: Not yet clear.

Drug Interactions

There is still a lack of research data and related reports on drug interactions of this product.

Storage

Sealed, store in a cool dark place

Packaging Specification

Peptide 8.75mg and hypoxanthine 1.25mg

Validity Period

24 months

Manufacturer

Harbin Medisan Pharmaceutical Co., Ltd.

  • Founded in:

    1996-06-21
  • Address:

    Beijing Road, Limin Development Zone, Harbin
  • Tax NO.:

    91230100607168790X
  • Registered Funds:

    316.35755 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.